Israel Englander Lineage Cell Therapeutics, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 168,978 shares of LCTX stock, worth $155,459. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,978

Previous 41,698 305.24%

Holding current value

$155,459

Previous $61,000 175.41%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.89 - $1.47 $113,279 - $187,101	127,280 Added 305.24%	168,978 $168,000
Q1 2024 May 15, 2024	SELL	$0.86 - $1.48 $14,018 - $24,124	-16,300 Reduced 28.1%	41,698 $61,000
Q4 2023 Feb 14, 2024	BUY	$0.91 - $1.35 $52,778 - $78,297	57,998 New	57,998 $63,000
Q1 2023 May 15, 2023	BUY	$1.2 - $1.53 $1.2 Million - $1.53 Million	1,003,084 Added 251.37%	1,402,123 $2.1 Million
Q4 2022 Feb 14, 2023	SELL	$1.02 - $1.5 $109,419 - $160,911	-107,274 Reduced 21.19%	399,039 $467,000
Q3 2022 Nov 14, 2022	SELL	$1.13 - $1.77 $580,970 - $910,015	-514,133 Reduced 50.38%	506,313 $572,000
Q2 2022 Aug 15, 2022	BUY	$1.12 - $1.61 $942,987 - $1.36 Million	841,953 Added 471.7%	1,020,446 $1.61 Million
Q1 2022 May 16, 2022	SELL	$1.21 - $2.48 $187,219 - $383,722	-154,727 Reduced 46.43%	178,493 $275,000
Q4 2021 Feb 14, 2022	BUY	$1.84 - $2.68 $577,382 - $840,970	313,795 Added 1615.42%	333,220 $816,000
Q3 2021 Nov 15, 2021	BUY	$2.26 - $2.86 $43,900 - $55,555	19,425 New	19,425 $49,000
Q2 2021 Aug 16, 2021	SELL	$2.17 - $3.0 $3.09 Million - $4.28 Million	-1,425,776 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.77 - $3.1 $1.9 Million - $3.32 Million	1,071,023 Added 301.91%	1,425,776 $3.35 Million
Q4 2020 Feb 16, 2021	SELL	$0.95 - $1.83 $2,636 - $5,078	-2,775 Reduced 0.78%	354,753 $624,000
Q3 2020 Nov 16, 2020	BUY	$0.75 - $1.09 $257,496 - $374,227	343,328 Added 2417.8%	357,528 $335,000
Q2 2020 Aug 14, 2020	BUY	$0.71 - $1.18 $10,082 - $16,756	14,200 New	14,200 $12,000

Others Institutions Holding LCTX

# of Institutions

125

Shares Held

94.5M

Call Options Held

31.3K

Put Options Held

400

View Full List

About Lineage Cell Therapeutics, Inc.

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $156M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

More about LCTX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account